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The assessment of risk to human health from contaminated land is based on a 
comparison of predicted human exposure to a contaminant with a Health Criteria Value 
(HCV) that represents an exposure below which there is thought to be little or no risk to 
human health. Most assessment tools, such as the Contaminated Land Exposure 
Assessment Model (CLEA), use estimates of exposure based on intake (consumption rate) 
rather than on measures of uptake (the amount of contaminant which enters the 
bloodstream), thus allowing comparison with HCVs, which are also based on intake 
apposed to uptake. Soil Guideline Values (SGVs) derived using the CLEA model assume 
that a soil contaminant will be taken up into the body to the same extent as from the 
medium of exposure used to derive the oral HCV (e.g. soluble salts of Cr(VI)). This is a 
conservative assumption as contaminants can be tightly bound to other soil components, 
thus reducing bioavailability (the fraction of a contaminant that can be absorbed by the 
body).  
There is increasing interest in the potential for information on the bioavailability 
of soil contaminants to be used to refine a risk assessment. Bioavailability, unfortunately, 
is a difficult quantity to measure because of the need to model contaminant absorption in 
humans. This inevitably involves in vivo animal testing, thus making it impractical for 
routine site specific risk assessment. Oral bioaccessibility (the fraction of a contaminant 
that is soluble in the gastrointestinal environment and is available for absorption), 
however, can be measured using laboratory-based in vitro methods, making it better 
suited to routine risk assessment. 
Between 1830 and 1968 Glasgow was home to one of the world’s largest 
producers of chromium based chemicals. Chromite ore processing residues (COPR) 
arising from the factory were used as infill material across large areas of SE Glasgow, 
resulting in widespread land contamination with Cr(VI), a known carcinogen of 
significant mobility. As part of a current research project into bioaccessibility and the 
human health risks posed by urban chromium contaminated land, it is planned to identify 
a small number of locations in Glasgow with elevated Cr(VI) concentrations that are 
readily accessible to the public. These sites will undergone bioaccessibility assessment 
using a refined Physiologically Based Extraction Test (PBET), first proposed by Ruby et 
al. (1996), which is essentially a two-stage sequential extraction using various simulated 
biofluids. This project will extend previous work performed under the NERC URGENT 
Programme on chromite ore processing residue issues in Glasgow (Farmer et al., 2002: 
Geelhoed et al., 2002). 
To this end twenty-seven surface soil samples (the top 15 cm) have been collected 
from a range of land types across Greater Glasgow, including city parks, recreational 
ground and tended open land. These samples have undergone microwave assisted acid 
digestion, using HF/HNO3 (1:9), and analysed for Cr by ICP-OES. Total Cr 
concentrations were found to range from 87 to 3560 mg/kg, thirteen of which showed 
concentrations of Cr over 130 mg/kg, with six over 200 mg/kg. Under the CLEA model 
these sites could be considered to pose a possible human health risk, 130 and 200 mg/kg 
being the SGVs for residential land with and without plant uptake. Further investigation, 
using an alkaline digestion method (USEPA method 3060A) and UV/vis 
spectrophotometry (diphenylcarbazide at 540nm), has shown that of these thirteen 
samples one has a Cr(VI) concentration in excess of 1000 mg/kg, while another was 
measured at 171 mg/kg.  
The next step will be to investigated the bioaccessibility of Cr(VI) in these 
samples using a refined PBET method. This method will simulate the physical and 
chemical conditions of the gastrointestinal environment, therefore providing information 
about the solubility of Cr(VI) in contaminated soil following ingestion.   
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